Skip to content
GLP-1 Scorecard
Menu
Site position #159

GOAL.MD

By GLP-1 ScorecardUpdated

Compounded injection plans with manual reorders, plus separately priced physician care for brand-name prescriptions.

Our take

GOAL.MD's appeal is control over compounded reorders. We would try its month-to-month option before prepaying a year: it asks before another charge, but makes paid orders final.

Visit GOAL.MDWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$179/mo (month-to-month, compounded)
Tirzepatide
$249/mo (flat-dose monthly, compounded)
Coverage
Advertises all 50 states; clinical and pharmacy eligibility apply
Brand-name
Yes

Weigh GOAL.MD against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives.

Semaglutide is advertised at $179 month-to-month or $1,188 upfront for twelve months. Tirzepatide is $249 month-to-month or $1,908 upfront. The annual equivalents of $99/$159 are not monthly card charges.

The annual discount is a decision about cash committed

Three-, six- and twelve-month terms require prepayment. Compare the money due today with the month-to-month option before choosing a lower equivalent. The six-month cost guide separates those purchases.

Approving a refill and getting a refund are different things

GOAL.MD says it asks before a compounded reorder, then makes paid orders final. Clarify declined-prescription and early-stop rules before prepaying. Our cancellation guide separates stopping another charge from recovering money already paid.

Brand-name care has a separate fee and conflicting billing language

The brand program advertises a $95 monthly physician fee, with medication purchased separately. The same page describes both automatic membership billing and a one-time payment with manual continuation. Its terms and billing policy describe automatic renewal. We would resolve that disagreement before enrolling; the compounded program's refill permission should not be assumed to apply here.

The terms exclude laboratory work and other outside services from the physician fee. They also make a paid service cycle final once clinical work begins, without prorating. Compare the care fee, pharmacy bill and any testing as separate costs.

GOAL also advertises brand-name oral Wegovy with medication purchased separately. This is an oral brand option; it does not establish access to compounded oral semaglutide or tirzepatide.

Nutrition support is included; confirm the actual care arrangement

The compounded program advertises physician care, medication, a nutrition coordinator and expedited shipping. Availability still depends on clinical, state and pharmacy eligibility. Ask who will prescribe and dispense for you; a national service statement does not settle either assignment. Use our pharmacy verification guide to check the dispenser once named.

The authors page names physicians and identifies Pro Medical Reviews LLC as its content publisher. That publisher identity is not a substitute for the legal practice treating you. A listed NPI also does not establish a current license in your state.

The public privacy page provides only a short summary. Ask for the applicable patient privacy notice before sending health records.

Get the prescription details before choosing a long term

Advertised injection prices cover each prescribed dose. Confirm ingredients, concentration, supplied quantity and delivery schedule. The vial-label guide explains milligrams versus syringe units. Compounded preparations are not FDA-approved.

The physician history needs its later outcome too

GOAL identifies Dr. Michael Mimlitz as chief physician and co-founder. A 2016 DOJ release records his guilty plea concerning misbranded HGH. Missouri's orders record revocation, a new license under probation in 2017, and termination of restrictions in March 2019.

On October 29, Missouri's active-license search listed license 2017006602 with expiration January 31, 2027 and no current discipline, while recording prior actions. That is a Missouri licensing finding, not verification of every state license or your assigned clinician.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value65/100
Dose & formulation86/100
Clinical oversight68/100
Labs & monitoring53/100
Fulfillment77/100
Contract terms55/100

Strengths

  • Compounded reorders require permission before charging
  • Advertised injection price stays the same across prescribed doses
  • Nutrition support and expedited shipping included in compounded plans
  • Advertises brand-name oral Wegovy access; medication costs extra

What to consider

  • Compounded orders become non-refundable when payment is processed
  • Lowest monthly equivalents require a twelve-month upfront payment
  • Brand-access page gives conflicting automatic-billing statements
  • Confirm the assigned dispensing pharmacy and its credentials
  • GOAL identifies a physician with historical discipline; Missouri ended restrictions in 2019 and records no current discipline at the October 2026 check

Bottom line — Grade C

Best for: Self-pay shoppers who want to authorize each compounded refill and will use the included nutrition support.

Look elsewhere if: Anyone needing unused compounded treatment refunded, or expecting brand-name medication inside the physician-service fee.

Site position #159 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest GOAL.MD — the realistic shortlist.

Somi Health#158

Somi Health is a telehealth weight-loss provider offering compounded GLP-1 medications - compounded semaglutide and tirzepatide injections plus an oral semaglutide tablet.

Trava Health#160

Houston-based DTC telehealth offering compounded semaglutide+B12 and tirzepatide+B12 through SIX named 503A compounding pharmacy partners disclosed on Trava's own Terms + Telehealth Consent pages (Postmeds/TruePill, EHT/Curexa, Apostrophe, XeCare, Wells American/Promed, Optimal Balance/OBP).

VyrarX#161

VyrarX is a LegitScript-certified telehealth platform offering compounded semaglutide (from $179/month) and compounded tirzepatide (from $329/month) via weekly injection, prescribed by licensed US physicians.

Noom Med#162

Noom Med integrates GLP-1 medication access with Noom's proven cognitive behavioral therapy curriculum, 1-on-1 dietitian coaching, and dedicated care team — the most comprehensive psychology-plus-medication program available.

PauseRX#163

PauseRX is a nationwide compounded GLP-1 telehealth platform notable for its transparency: it names its 503A pharmacy partner (Strive Pharmacy in Gilbert, AZ), its physician network (Beluga Health), and publishes a full FDA compounded-medication disclaimer.

System Labs#102

Advertises a $99 introductory month and $179 ongoing compounded injection program, with The Pharmacy Hub named as a partner and prescription supply, lab cost and cancellation instructions still needing confirmation.

The 20 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect GOAL.MD's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on GOAL.MD's site. Not medical advice; see our disclosure.

← Back to the scorecard